Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • terabase
    Junior Member
    • Feb 2008
    • 4

    Does anyone have a SOLID system running

    I am hearing more and more rumors that the SOLID system does not work or that ABI is having a really hard time getting the installed systems running. We are currently deciding what to buy - the Illumina Genome Analyzer or the Applied SOLID system.

    DOES ANYONE USE THE SOLID SYSTEM ?
  • Chipper
    Senior Member
    • Mar 2008
    • 323

    #2
    Originally posted by terabase View Post
    I am hearing more and more rumors that the SOLID system does not work or that ABI is having a really hard time getting the installed systems running. We are currently deciding what to buy - the Illumina Genome Analyzer or the Applied SOLID system.

    DOES ANYONE USE THE SOLID SYSTEM ?
    Yes it does work well, perhaps the rumor has to do with the fact that AB is releasing a new chemistry now for 50 bp reads. Don't know which system is in the lead for bases or tags per day or $ though. Perhaps the polonator if it is working as claimed...

    Comment

    • solidifier
      Junior Member
      • Feb 2008
      • 5

      #3
      Yes, at Rutgers we've already run genomic fragment libraries, mate-pair libraries, and small RNA libraries. It's VERY early in data analysis but the results are looking very nice. Better depth than advertised.

      Comment

      • cgb
        Member
        • May 2008
        • 50

        #4
        you can get between 400 MB and > 1GB *per day* from either SOLiDs or GAIIs. Illumina base quality can be between Q30-Q40 if recalibrated properly. SOLiD 2 color base changes can be >Q30 as long as you have enough read length to get you a good alignment (in colorspace) - (so i guess you need all of the latest tweaks).

        Comment

        • terabase
          Junior Member
          • Feb 2008
          • 4

          #5
          Thanks for the comments.
          I guess the situation is changing somewhat. A few months ago Illumina was clearly the leader in short read sequencing. Meanwhile an increasing number of labs is generating data with the SOLID system and ABI seems to catch up rapidly. The Illumina sales reps are still heavily bashing the SOLID System as not working - out of obvious reasons.

          Comment

          • Chipper
            Senior Member
            • Mar 2008
            • 323

            #6
            Originally posted by terabase View Post
            Thanks for the comments.
            I guess the situation is changing somewhat. A few months ago Illumina was clearly the leader in short read sequencing. Meanwhile an increasing number of labs is generating data with the SOLID system and ABI seems to catch up rapidly. The Illumina sales reps are still heavily bashing the SOLID System as not working - out of obvious reasons.
            Lol, have they tried it? It's not like the Illumina is without problems either. But both seems to yield similar number of aligned sequences. My impression is that the sample prep is somewhat more tricky with the SOLiD, but it should not be a big difference. Just qurious, why is no one considering the Helicos? Is it because of price, availability or lack of real data? On (web)paper it looks like the best instrument when it comes to sample handling, price per sample etc.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM
            • GATTACAT
              Reply to Nine Things a Sample Prep Scientist Thinks About Before Sequencing
              by GATTACAT
              Love this - good data definitely starts from good input, and poor input can only give relatively poor data. I particularly like the mention of Nanodrop/absorbance based methods for quantification. It's such a toss up if you'll get an accurate reading or what amounts to a randomly generated number, and a lot of library/sequencing related issues can be traced back to poor quant.
              07-01-2026, 11:43 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            20 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-09-2026, 10:04 AM
            0 responses
            30 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-08-2026, 10:08 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-07-2026, 11:05 AM
            0 responses
            34 views
            0 reactions
            Last Post SEQadmin2  
            Working...